Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Amortizatization of Intangibles: 2018-2024

Historic Amortizatization of Intangibles for Silence Therapeutics (SLN) over the last 7 years, with Dec 2024 value amounting to $257,000.

  • Silence Therapeutics' Amortizatization of Intangibles rose 15.38% to $75,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $271,000, marking a year-over-year increase of 32.73%. This contributed to the annual value of $257,000 for FY2024, which is 1.98% up from last year.
  • According to the latest figures from FY2024, Silence Therapeutics' Amortizatization of Intangibles is $257,000, which was up 1.98% from $252,000 recorded in FY2023.
  • In the past 5 years, Silence Therapeutics' Amortizatization of Intangibles ranged from a high of $257,000 in FY2024 and a low of $22,014 during FY2021.
  • For the 3-year period, Silence Therapeutics' Amortizatization of Intangibles averaged around $242,000, with its median value being $252,000 (2023).
  • Per our database at Business Quant, Silence Therapeutics' Amortizatization of Intangibles tumbled by 32.95% in 2020 and then soared by 885.73% in 2022.
  • Over the past 5 years, Silence Therapeutics' Amortizatization of Intangibles (Yearly) stood at $25,683 in 2020, then declined by 14.29% to $22,014 in 2021, then skyrocketed by 885.73% to $217,000 in 2022, then increased by 16.13% to $252,000 in 2023, then grew by 1.98% to $257,000 in 2024.